van Vugt,M.A., Br and Medema,R.H. (2004) Polo-like kinase-1 controls recovery from a G2 DNA damage-induced arrest in mammalian cells. Mol. Cell 15 (5), 799-811.
van Vugt,M.A. et al. (2004) Polo-like kinase-1 is required for bipolar spindle formation but is dispensable for anaphase promoting complex/Cdc20 activation and initiation of cytokinesis. J. Biol. Chem. 279 (35), 36841-36854.
Weichert,W., Schmidt,M., Gekeler,V., Denkert,C., Stephan,C., Jung,K., Loening,S., Dietel,M. and Kristiansen,G. (2004) Polo-like kinase 1 is overexpressed in prostate cancer and linked to higher tumor grades. Prostate 60 (3), 240-245.
Gunawardena,R.W., Siddiqui,H., Solomon,D.A., Mayhew,C.N., Held,J., Angus,S.P. and Knudsen,E.S. (2004) Hierarchical requirement of SWI/SNF in retinoblastoma tumor suppressor-mediated repression of Plk1. J. Biol. Chem. 279 (28), 29278-29285.
Ando,K., Ozaki,T., Yamamoto,H., Furuya,K., Hosoda,M., Hayashi,S., Fukuzawa,M. and Nakagawara,A. (2004) Polo-like kinase 1 (Plk1) inhibits p53 function by physical interaction and phosphorylation. J. Biol. Chem. 279 (24), 25549-25561.
Litvak,V., Argov,R., Dahan,N., Ramachandran,S., Amarilio,R., Shainskaya,A. and Lev,S. (2004) Mitotic phosphorylation of the peripheral Golgi protein Nir2 by Cdk1 provides a docking mechanism for Plk1 and affects cytokinesis completion. Mol. Cell 14 (3), 319-330.